CML	Chronic Myeloid Leukemia
PK	Protein Kinase
TK	Tyrosine Kinase
TKI	Tyrosine Kinase Inhibitor
RTK	Receptor Tyrosine Kinase
NRTK	Non-Receptor Tyrosine Kinase
VEGFR	Vascular Endothelial Growth Factor
PDGF	Platelet Derived Growth Factor
Src	Sarcoma
JAK	Janus Kinase
ABL	Abelson (gene)
BCR	Breakpoint Cluster Region (gene)
PI3K	Phosphoinositide 3-Kinase
STAT	Signal Transducer and Activator of Transcription (protein)
CP	Chronic Phase
AP	Accelerated Phase
BC	Blast Crisis
Asp	Aspartate
Phe	Phenylalanine
Gly	Glycine
ATP	Adenosine Triphosphate
DFG	Aspartate-Phenilalanine-Glycine
Thr	Threonine
HSCT	Hematopoietic Stem Cells Transplantation
HCT	Hematopoietic Cell Transplantation
INF	Interferon
CHR	Complete Hematological Response
MMR	Major Molecular Response
CCR	Complete Cytogenetic Remission
Ph	Philadelphia (chromosome)
Ph+	Philadelphia positive
P-gp	Glycoprotein P
OCT	Organic Cation Transporter
PDGFR	Platelet Derived Growth Factor Receptor
UK	United Kingdom
NAACCR	North American Association of Central Cancer Registries
ELN	European Leukemia Net
NCCN	National Comprehensive Cancer Network
CI	Confidence Interval
STIM	Stop Imatinib
LSC	Leukemic Stem Cells
ALL	Acute Lymphoblastic Leukemia
CMR	Complete Molecular Response
FDA	Food and Drug Administration
EMA	European Medicinal Agency
R/I	Resistance/Intolerance
SAE	Severe Adverse Event
HLA	Human Leukocyte Antigen
CIBMTR	Center for International Blood and Marrow Transplant Research
OS	Overall Survival
LFS	Leukemia-Free Survival
MSD	Matching Sibling Donor
HCT	Hematopoietic Cell Transplantation
HRQOL	Health-Related Quality of Life
ISD	Identical Sibling Donor
TFR	Treatment-free Remission
QoL	Quality of Life
DMR	Deep Molecular Response
EURO-SKI	European Stop Tyrosine Kinase Inhibitor
ESMO	European Society for Medical Oncology
RQ-PCR	Real-time Quantitative Polymerase Chain Reaction